Peanut allergies: Parents worry after Palforzia drug sales flop
World-first peanut allergy drug Palforzia’s poor sales spark concerns over future drug research.
Stay updated with breaking news from Tim Van Biesen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
World-first peanut allergy drug Palforzia’s poor sales spark concerns over future drug research.
/PRNewswire/ -- Bain & Company, a top global management consultancy, and Trinity Life Sciences, a leader in global life sciences commercialization solutions,...
/PRNewswire/ -- Hero, the market leader for digital in-home care, focused today on medication management, has created an Advisory Board comprising recognized...
NEW YORK, Jan. 20, 2022 /PRNewswire/ -- Hero, the market leader for digital in-home care, focused today on medication management, has created an A...
/PRNewswire/ -- Hero, the market leader for digital in-home care, focused today on medication management, has created an Advisory Board comprising recognized...